Domestic drug makers have welcomed the government’s decision to continue with 100 per cent foreign direct investment (FDI) in the domestic pharmaceutical sector and make the Competition Commission of India (CCI) solely responsible for the scrutiny of mergers and acquisitions in the drug manufacturing field.
Industry representatives, reacting to the Prime Minister Manmohan Singh’s endorsement of the recommendations made by a high-level committee headed by Planning Commission member Arun Maira on pharma takeovers, said the government should now formulate a policy framework.
1499
1999
216
260
2099
3133
1500
3000
498
999
2400
2904
23982
26932
125
210
307
399
39483
59823
2479
3719
1790
2166